Literature DB >> 10484526

Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells.

D M Filipovic1, X Meng, W B Reeves.   

Abstract

Oxidant-induced cell injury has been implicated in the pathogenesis of several forms of acute renal failure. The present studies examined whether activation of poly(ADP-ribose)polymerase (PARP) by oxidant-induced DNA damage contributes to oxidant injury of renal epithelial cells. H2O2 exposure resulted in an increase in PARP activity and decreases in cell ATP and NAD content. These changes were significantly inhibited by 10 mM 3-aminobenzamide (3-ABA), a PARP inhibitor. In contrast, H2O2-induced DNA damage was not prevented by 3-ABA. Exposure of LLC-PK(1) cells to 1 mM H2O2 for 2 h induced necrotic cell death as measured by increased lactate dehydrogenase (LDH) release. 3-ABA completely prevented the H2O2-induced LDH release. Live/dead fluorescent staining confirmed the protection by 3-ABA. These results are consistent with the view that oxidant-induced DNA damage activates PARP and that the subsequent ATP and NAD depletion contribute to necrotic cell death. Of note, although protected from necrosis, cells treated with H2O2 and 3-ABA underwent apoptosis as evidenced by DNA fragmentation and bis-benzimide staining. In conclusion, activation of PARP contributes to oxidant-induced ATP depletion and necrosis in LLC-PK1 cells. However, PARP inhibition may target cells toward an apoptotic form of cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484526     DOI: 10.1152/ajprenal.1999.277.3.F428

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Congener-specific polychlorinated biphenyl-induced cell death in human kidney cells in vitro: potential role of caspase.

Authors:  Y Q Chen; S De; S Ghosh; S K Dutta
Journal:  Int J Toxicol       Date:  2006 Sep-Oct       Impact factor: 2.032

2.  Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage.

Authors:  El Bachir Affar; Rashmi G Shah; Annie-Karine Dallaire; Vincent Castonguay; Girish M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 3.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

Review 4.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

5.  Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis.

Authors:  Enlong Ma; Ping Chen; Heather M Wilkins; Tao Wang; Russell H Swerdlow; Qi Chen
Journal:  Free Radic Biol Med       Date:  2017-09-12       Impact factor: 7.376

6.  Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats.

Authors:  Ilijana Grigorov; Desanka Bogojević; Sofija Jovanović; Anja Petrović; Svetlana Ivanović-Matić; Lidija Zolotarevski; Goran Poznanović; Vesna Martinović
Journal:  J Physiol Biochem       Date:  2014-03-07       Impact factor: 4.158

7.  The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress.

Authors:  Hakjoo Lee; Sylvia B Smith; Shey-Shing Sheu; Yisang Yoon
Journal:  J Biol Chem       Date:  2020-04-03       Impact factor: 5.157

8.  PARP-1 inhibits glycolysis in ischemic kidneys.

Authors:  Kishor Devalaraja-Narashimha; Babu J Padanilam
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

9.  Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging.

Authors:  Matthias Altmeyer; Michael O Hottiger
Journal:  Aging (Albany NY)       Date:  2009-05-20       Impact factor: 5.682

10.  Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans.

Authors:  Reid Aikin; Lawrence Rosenberg; Steven Paraskevas; Dusica Maysinger
Journal:  J Mol Med (Berl)       Date:  2004-04-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.